MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

Search

Edwards Lifesciences Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

71.76 -0.88

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

71.2

Max

72.43

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-2.7B

346M

Pardavimai

31M

1.4B

P/E

Sektoriaus vid.

30.714

63.778

Pelnas, tenkantis vienai akcijai

0.59

Pelno marža

24.989

Darbuotojai

15,800

EBITDA

55M

484M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+6.93% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-04-23

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-1.1B

42B

Ankstesnė atidarymo kaina

72.64

Ankstesnė uždarymo kaina

71.76

Naujienos nuotaikos

By Acuity

57%

43%

310 / 386 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bullish Evidence

Edwards Lifesciences Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2024-07-15 13:57; UTC

Įsigijimai, susijungimai, perėmimai

Edwards Lifesciences to Buy Innovalve for $300 Million

2024-10-25 09:10; UTC

Uždarbis

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

2024-10-25 08:35; UTC

Uždarbis

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

2024-09-03 20:38; UTC

Įsigijimai, susijungimai, perėmimai

Edwards Lifesciences: After Recent Accelerated Repurchase Agreement and August Buybacks Via 10b5-1 Agreement and Open Market Repurchases, Company Has $1.4B in Remaining Authorization

2024-09-03 20:37; UTC

Įsigijimai, susijungimai, perėmimai

Edwards Lifesciences Completes Sale of Critical Care Group to Becton Dickinson for $4.2B

2024-09-03 20:36; UTC

Įsigijimai, susijungimai, perėmimai

Edwards Lifesciences Authorizes $1.5B of Additional Share Repurchases

2024-07-25 09:02; UTC

Uždarbis
Karštos akcijos

Stocks to Watch Thursday: Ford, IBM, Chipotle, American Airlines -- WSJ

2024-07-25 08:40; UTC

Svarbiausios naujienos

These Stocks Are Moving the Most Today: Ford, Tesla, Alphabet, Nvidia, Super Micro, IBM, ServiceNow, Chipotle, and More -- Barrons.com

2024-07-24 20:17; UTC

Uždarbis

Edwards Lifesciences: Expects 2024 Edwards Sales Growth of 8% to 10% >EW

2024-07-24 20:15; UTC

Įsigijimai, susijungimai, perėmimai

Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix

2024-07-24 20:15; UTC

Uždarbis

Edwards Lifesciences 2Q Sales $1.39B >EW

2024-07-24 20:15; UTC

Uždarbis

Edwards Lifesciences 2Q Net $366.3M >EW

2024-07-24 20:15; UTC

Uždarbis

Edwards Lifesciences 2Q Adj EPS 70c >EW

2024-07-24 20:15; UTC

Uždarbis

Edwards Lifesciences 2Q EPS 61c >EW

2024-07-15 13:42; UTC

Įsigijimai, susijungimai, perėmimai

Edwards Lifesciences to Buy Innovalve for $300M

2024-07-15 13:01; UTC

Įsigijimai, susijungimai, perėmimai

Edwards Lifesciences: SAPIEN M3 Remains on Track to Become First Approved Transfemoral TMVR System in Europe by End of 2025 >EW

2024-07-15 13:01; UTC

Įsigijimai, susijungimai, perėmimai

Edwards Lifesciences: Acquisition Enhances TMVR Technologies to Address Large Unmet Structural Heart Patient Needs >EW

2024-07-15 13:00; UTC

Įsigijimai, susijungimai, perėmimai

Edwards Lifesciences to Acquire Innovalve Bio Medical Ltd., Early-Stage Transcatheter Mitral Valve Replacement Co >EW

2024-07-15 13:00; UTC

Įsigijimai, susijungimai, perėmimai

Edwards Lifesciences To Acquire Innovalve >EW

2024-06-04 17:26; UTC

Įsigijimai, susijungimai, perėmimai

Edwards Lifesciences Deal A Clear Win For Becton Dickinson, Analysts Say -- Analysis

2024-06-03 13:26; UTC

Įsigijimai, susijungimai, perėmimai

Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal -- IBD

2024-06-03 12:25; UTC

Svarbiausios naujienos
Įsigijimai, susijungimai, perėmimai

Becton Dickinson to Acquire Edwards Lifesciences' Unit for $4.2 Billion in Cash -- Update

2024-06-03 11:03; UTC

Svarbiausios naujienos
Įsigijimai, susijungimai, perėmimai

Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2B in Cash

2024-06-03 10:40; UTC

Įsigijimai, susijungimai, perėmimai

Edwards Lifesciences To Sell Its Critical Care Product Group For $4.2 Billion To Becton Dickinson -- MarketWatch

2024-06-03 10:32; UTC

Įsigijimai, susijungimai, perėmimai

Becton Dickinson: Acquired Business Has About 4,500 Employees >BDX EW

2024-06-03 10:31; UTC

Įsigijimai, susijungimai, perėmimai

Becton Dickinson: Acquired Business Generated More Than $900 Million Revenue in 2023 >BDX

2024-06-03 10:31; UTC

Įsigijimai, susijungimai, perėmimai

Becton Dickinson: Deal Expands Portfolio of Smart Connected Care Solutions >BDX EW

2024-06-03 10:30; UTC

Įsigijimai, susijungimai, perėmimai

Becton Dickinson to Buy Edwards Lifesciences Critical Care Product Group for $4.2 Billion >BDX EW

2024-06-03 10:30; UTC

Įsigijimai, susijungimai, perėmimai

BD To Acquire Edwards Lifesciences' Critical Care Product Group For $4.2 Billion To Expand Smart Connected Care Solutions And Become An Advanced Monitoring Technology Leader >BDX EW

2024-04-26 20:10; UTC

Uždarbis

This 'Critical' Business Helped Edwards Lifesciences Offset Its TAVR Miss -- IBD

Akcijų palyginimas

Kainos pokytis

Edwards Lifesciences Corp Prognozė

Kainos tikslas

By TipRanks

6.93% į viršų

12 mėnesių prognozė

Vidutinis 77.5 USD  6.93%

Aukščiausias 90 USD

Žemiausias 60 USD

Remiantis 19 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Edwards Lifesciences Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

19 ratings

7

Pirkti

11

Laikyti

1

Parduoti

Techninis įvertinimas

By Trading Central

71.075 / 72.24Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bullish Evidence

Vidutinės trukmės periodas

Bullish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

310 / 386 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Meškų rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.